To Take Certain Actions Under the African Growth and Opportunity Act, and for Other Purposes, 81077-81081 [2010-32610]
Download as PDF
81077
Presidential Documents
Federal Register
Vol. 75, No. 245
Monday, December 27, 2010
Title 3—
Proclamation 8618 of December 21, 2010
The President
To Take Certain Actions Under the African Growth and Opportunity Act, and for Other Purposes
By the President of the United States of America
A Proclamation
1. Section 506A(a)(1) of the Trade Act of 1974, as amended (the ‘‘1974
Act’’) (19 U.S.C. 2466a(a)(1)), as added by section 111(a) of the African
Growth and Opportunity Act (title I of Public Law 106–200) (AGOA), authorizes the President to designate a country listed in section 107 of the AGOA
(19 U.S.C. 3706) as a ‘‘beneficiary sub-Saharan African country’’ if the President determines that the country meets the eligibility requirements set forth
in section 104 of the AGOA (19 U.S.C. 3703), as well as the eligibility
criteria set forth in section 502 of the 1974 Act (19 U.S.C. 2462).
2. Section 104 of the AGOA authorizes the President to designate a country
listed in section 107 of the AGOA as an ‘‘eligible sub-Saharan African
country’’ if the President determines that the country meets certain eligibility
requirements.
3. In Proclamation 7657 of March 28, 2003, the President designated the
Democratic Republic of Congo (DRC) as an eligible sub-Saharan African
country pursuant to section 104 of the AGOA.
4. Proclamation 7657 also authorized the United States Trade Representative
(USTR) to exercise the authority provided to the President under section
506A(a)(1) of the 1974 Act to designate the DRC as a beneficiary subSaharan African country.
5. Pursuant to the authority delegated to the USTR, on October 31, 2003,
the USTR designated the DRC as a beneficiary sub-Saharan African country
(68 FR 62158–04).
6. Section 506A(a)(3) of the 1974 Act (19 U.S.C. 2466a(a)(3)) authorizes
the President to terminate the designation of a country as a beneficiary
sub-Saharan African country for purposes of section 506A if he determines
that the country is not making continual progress in meeting the requirements
described in section 506A(a)(1) of the 1974 Act.
erowe on DSK5CLS3C1PROD with MISCELLANEOUS
7. Pursuant to section 506A(a)(3) of the 1974 Act, I have determined that
the DRC is not making continual progress in meeting the requirements
described in section 506A(a)(1) of the 1974 Act. Accordingly, I have decided
to terminate the designation of the DRC as a beneficiary sub-Saharan African
country for purposes of section 506A of the 1974 Act, effective on January
1, 2011.
8. On April 22, 1985, the United States and Israel entered into the Agreement
on the Establishment of a Free Trade Area between the Government of
the United States of America and the Government of Israel (the ‘‘USIFTA’’),
which the Congress approved in the United States-Israel Free Trade Area
Implementation Act of 1985 (the ‘‘USIFTA Act’’) (19 U.S.C. 2112 note).
9. Section 4(b) of the USIFTA Act provides that, whenever the President
determines that it is necessary to maintain the general level of reciprocal
and mutually advantageous concessions with respect to Israel provided for
by the USIFTA, the President may proclaim such withdrawal, suspension,
modification, or continuance of any duty, or such continuance of existing
VerDate Mar<15>2010
07:36 Dec 23, 2010
Jkt 223001
PO 00000
Frm 00001
Fmt 4705
Sfmt 4790
E:\FR\FM\27DED0.SGM
27DED0
81078
Federal Register / Vol. 75, No. 245 / Monday, December 27, 2010 / Presidential Documents
duty-free or excise treatment, or such additional duties as the President
determines to be required or appropriate to carry out the USIFTA.
10. In order to maintain the general level of reciprocal and mutually advantageous concessions with respect to agricultural trade with Israel, on July
27, 2004, the United States entered into an agreement with Israel concerning
certain aspects of trade in agricultural products during the period January
1, 2004, through December 31, 2008 (the ‘‘2004 Agreement’’).
11. In Proclamation 7826 of October 4, 2004, consistent with the 2004
Agreement, the President determined, pursuant to section 4(b) of the USIFTA
Act, that it was necessary in order to maintain the general level of reciprocal
and mutually advantageous concessions with respect to Israel provided for
by the USIFTA, to provide duty-free access into the United States through
December 31, 2008, for specified quantities of certain agricultural products
of Israel.
12. On December 10, 2008, the United States entered into an agreement
with Israel to extend the period that the 2004 Agreement is in force through
December 31, 2009, to allow additional time for the two governments to
conclude an agreement to replace the 2004 Agreement.
13. In Proclamation 8334 of December 31, 2008, the President determined
that it was necessary in order to maintain the general level of reciprocal
and mutually advantageous concessions with respect to Israel provided for
by the USIFTA to extend such duty-free treatment through December 31,
2009. In that proclamation, the President also modified the Harmonized
Tariff Schedule of the United States (HTS) to provide duty-free access into
the United States through December 31, 2009, for specified quantities of
certain agricultural products of Israel.
14. On December 6, 2009, the United States entered into a further agreement
with Israel to extend the period that the 2004 Agreement is in force through
December 31, 2010, to allow for further negotiations on an agreement to
replace the 2004 Agreement.
15. In Proclamation 8467 of December 23, 2009, I determined that it was
necessary in order to maintain the general level of reciprocal and mutually
advantageous concessions with respect to Israel provided for by the USIFTA
to extend such duty-free treatment through December 31, 2010. In that
proclamation, I also modified the HTS to provide duty-free access into
the United States through December 31, 2010, for specified quantities of
certain agricultural products of Israel.
16. On December 12, 2010, the United States entered into a further agreement
with Israel to extend the period that the 2004 Agreement is in force through
December 31, 2011, to allow for further negotiations on an agreement to
replace the 2004 Agreement.
erowe on DSK5CLS3C1PROD with MISCELLANEOUS
17. Pursuant to section 4(b) of the USIFTA Act, I have determined that
it is necessary, in order to maintain the general level of reciprocal and
mutually advantageous concessions with respect to Israel provided for by
the USIFTA, to provide duty-free access into the United States through
the close of December 31, 2011, for specified quantities of certain agricultural
products of Israel.
18. During the Uruguay Round of Multilateral Trade Negotiations (the ‘‘Uruguay Round’’), a group of major trading countries agreed to reciprocal elimination of tariffs on certain pharmaceuticals and chemical intermediates,
and that participants in this agreement would revise periodically the list
of products subject to duty-free treatment. On December 13, 1996, as the
result of negotiations under the auspices of the World Trade Organization
(WTO), the United States and 16 other WTO members agreed to eliminate
tariffs on additional pharmaceuticals and chemical intermediates. The United
States implemented this agreement in Proclamation 6982 of April 1, 1997.
In 1998, the United States and 21 other WTO members negotiated a second
revision to the list of products subject to duty-free treatment. The United
VerDate Mar<15>2010
07:36 Dec 23, 2010
Jkt 223001
PO 00000
Frm 00002
Fmt 4705
Sfmt 4790
E:\FR\FM\27DED0.SGM
27DED0
Federal Register / Vol. 75, No. 245 / Monday, December 27, 2010 / Presidential Documents
81079
States implemented this revision in Proclamation 7207 of July 1, 1999.
In 2006, the United States and 30 other WTO members concluded negotiations, under the auspices of the WTO, on a further revision to the list
of pharmaceuticals and chemical intermediates subject to duty-free treatment.
The United States implemented this revision in Proclamation 8095 of December 29, 2006. The United States and 31 other WTO members have negotiated,
under the auspices of the WTO, a fourth revision to the list of pharmaceuticals
and chemical intermediates subject to duty-free treatment.
19. Section 111(b) of the Uruguay Round Agreements Act (URAA) (19 U.S.C.
3521(b)) authorizes the President under specified circumstances to proclaim
the modification of any duty or staged rate reduction of any duty set forth
in Schedule XX-United States of America, annexed to the Marrakesh Protocol
to the GATT 1994 (Schedule XX) for products that were the subject of
reciprocal duty elimination negotiations during the Uruguay Round, if the
United States agrees to such action in a multilateral negotiation under the
auspices of the WTO.
20. On September 15, 2010, consistent with section 115 of the URAA (19
U.S.C. 3524), the USTR submitted a report to the Committee on Ways
and Means of the House of Representatives and the Committee on Finance
of the Senate that set forth the proposed further revision to the list of
pharmaceuticals and chemical intermediates subject to duty-free treatment.
The consultation and layover period specified in section 115 ended on
November 14, 2010.
21. Pursuant to section 111(b) of the URAA, I have determined that Schedule
XX should be modified to reflect the implementation by the United States
of the multilateral agreement on certain pharmaceuticals and chemical intermediates negotiated under the auspices of the WTO. In addition, I have
determined that the pharmaceuticals appendix to the HTS should be modified
to reflect the duty eliminations provided for in that agreement.
22. Section 604 of the Trade Act of 1974, as amended (19 U.S.C. 2483),
authorizes the President to embody in the HTS the substance of the relevant
provisions of that Act, and of other Acts affecting import treatment, and
actions thereunder, including the removal, modification, continuance, or
imposition of any rate of duty or other import restriction.
NOW, THEREFORE, I, BARACK OBAMA, President of the United States
of America, by virtue of the authority vested in me by the Constitution
and the laws of the United States of America, including but not limited
to section 104 of the AGOA, title V and section 604 of the 1974 Act,
section 4 of the USIFTA Act, and section 111 of the URAA do proclaim
that:
(1) The designation of the DRC as a beneficiary sub-Saharan African country
for purposes of section 506A of the 1974 Act is terminated, effective on
January 1, 2011.
(2) In order to reflect in the HTS that beginning on January 1, 2011,
the DRC shall no longer be designated as a beneficiary sub-Saharan African
country, general note 16(a) to the HTS is modified by deleting ‘‘Democratic
Republic of Congo’’ from the list of beneficiary sub-Saharan African countries.
erowe on DSK5CLS3C1PROD with MISCELLANEOUS
(3) In order to implement U.S. tariff commitments under the 2004 Agreement through December 31, 2011, the HTS is modified as provided in
the Annex to this proclamation.
(4)(a) The modifications to the HTS made by the Annex to this proclamation shall be effective with respect to goods that are the product of Israel
and are entered, or withdrawn from warehouse for consumption, on or
after January 1, 2011.
(b) The provisions of subchapter VIII of chapter 99 of the HTS, as modified
by the Annex to this proclamation, shall continue in effect through December 31, 2011.
(5) In order to implement the multilateral agreement negotiated under
the auspices of the WTO to eliminate tariffs on certain pharmaceutical
VerDate Mar<15>2010
07:36 Dec 23, 2010
Jkt 223001
PO 00000
Frm 00003
Fmt 4705
Sfmt 4790
E:\FR\FM\27DED0.SGM
27DED0
81080
Federal Register / Vol. 75, No. 245 / Monday, December 27, 2010 / Presidential Documents
products and chemical intermediates, and to make technical corrections
in the tariff treatment accorded to such products, the HTS is modified
as set forth in Publication 4208 of the United States International Trade
Commission, entitled ‘‘Modifications to the Harmonized Tariff Schedule of
the United States to Implement Changes to the Pharmaceutical Appendix’’
(Publication 4208), which is incorporated by reference into this proclamation.
(6) The modifications to the HTS made in Publication 4208 shall be
effective with respect to articles entered, or withdrawn from warehouse
for consumption, on or after January 1, 2011.
(7) Any provisions of previous proclamations and Executive Orders that
are inconsistent with the actions taken in this proclamation are superseded
to the extent of such inconsistency.
IN WITNESS WHEREOF, I have hereunto set my hand this twenty-first
day of December, in the year of our Lord two thousand ten, and of the
Independence of the United States of America the two hundred and thirtyfifth.
VerDate Mar<15>2010
07:36 Dec 23, 2010
Jkt 223001
PO 00000
Frm 00004
Fmt 4705
Sfmt 4790
E:\FR\FM\27DED0.SGM
27DED0
OB#1.EPS
erowe on DSK5CLS3C1PROD with MISCELLANEOUS
Billing code 3195–W1–P
Federal Register / Vol. 75, No. 245 / Monday, December 27, 2010 / Presidential Documents
81081
[FR Doc. 2010–32610
Filed 12–23–10; 8:45 am]
VerDate Mar<15>2010
07:36 Dec 23, 2010
Jkt 223001
PO 00000
Frm 00005
Fmt 4705
Sfmt 4790
E:\FR\FM\27DED0.SGM
27DED0
ED27DE10.002
erowe on DSK5CLS3C1PROD with MISCELLANEOUS
Billing code 7020–02–C
Agencies
[Federal Register Volume 75, Number 247 (Monday, December 27, 2010)]
[Presidential Documents]
[Pages 81077-81081]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-32610]
Presidential Documents
Federal Register / Vol. 75, No. 245 / Monday, December 27, 2010 /
Presidential Documents
___________________________________________________________________
Title 3--
The President
[[Page 81077]]
Proclamation 8618 of December 21, 2010
To Take Certain Actions Under the African Growth
and Opportunity Act, and for Other Purposes
By the President of the United States of America
A Proclamation
1. Section 506A(a)(1) of the Trade Act of 1974, as
amended (the ``1974 Act'') (19 U.S.C. 2466a(a)(1)), as
added by section 111(a) of the African Growth and
Opportunity Act (title I of Public Law 106-200) (AGOA),
authorizes the President to designate a country listed
in section 107 of the AGOA (19 U.S.C. 3706) as a
``beneficiary sub-Saharan African country'' if the
President determines that the country meets the
eligibility requirements set forth in section 104 of
the AGOA (19 U.S.C. 3703), as well as the eligibility
criteria set forth in section 502 of the 1974 Act (19
U.S.C. 2462).
2. Section 104 of the AGOA authorizes the President to
designate a country listed in section 107 of the AGOA
as an ``eligible sub-Saharan African country'' if the
President determines that the country meets certain
eligibility requirements.
3. In Proclamation 7657 of March 28, 2003, the
President designated the Democratic Republic of Congo
(DRC) as an eligible sub-Saharan African country
pursuant to section 104 of the AGOA.
4. Proclamation 7657 also authorized the United States
Trade Representative (USTR) to exercise the authority
provided to the President under section 506A(a)(1) of
the 1974 Act to designate the DRC as a beneficiary sub-
Saharan African country.
5. Pursuant to the authority delegated to the USTR, on
October 31, 2003, the USTR designated the DRC as a
beneficiary sub-Saharan African country (68 FR 62158-
04).
6. Section 506A(a)(3) of the 1974 Act (19 U.S.C.
2466a(a)(3)) authorizes the President to terminate the
designation of a country as a beneficiary sub-Saharan
African country for purposes of section 506A if he
determines that the country is not making continual
progress in meeting the requirements described in
section 506A(a)(1) of the 1974 Act.
7. Pursuant to section 506A(a)(3) of the 1974 Act, I
have determined that the DRC is not making continual
progress in meeting the requirements described in
section 506A(a)(1) of the 1974 Act. Accordingly, I have
decided to terminate the designation of the DRC as a
beneficiary sub-Saharan African country for purposes of
section 506A of the 1974 Act, effective on January 1,
2011.
8. On April 22, 1985, the United States and Israel
entered into the Agreement on the Establishment of a
Free Trade Area between the Government of the United
States of America and the Government of Israel (the
``USIFTA''), which the Congress approved in the United
States-Israel Free Trade Area Implementation Act of
1985 (the ``USIFTA Act'') (19 U.S.C. 2112 note).
9. Section 4(b) of the USIFTA Act provides that,
whenever the President determines that it is necessary
to maintain the general level of reciprocal and
mutually advantageous concessions with respect to
Israel provided for by the USIFTA, the President may
proclaim such withdrawal, suspension, modification, or
continuance of any duty, or such continuance of
existing
[[Page 81078]]
duty-free or excise treatment, or such additional
duties as the President determines to be required or
appropriate to carry out the USIFTA.
10. In order to maintain the general level of
reciprocal and mutually advantageous concessions with
respect to agricultural trade with Israel, on July 27,
2004, the United States entered into an agreement with
Israel concerning certain aspects of trade in
agricultural products during the period January 1,
2004, through December 31, 2008 (the ``2004
Agreement'').
11. In Proclamation 7826 of October 4, 2004, consistent
with the 2004 Agreement, the President determined,
pursuant to section 4(b) of the USIFTA Act, that it was
necessary in order to maintain the general level of
reciprocal and mutually advantageous concessions with
respect to Israel provided for by the USIFTA, to
provide duty-free access into the United States through
December 31, 2008, for specified quantities of certain
agricultural products of Israel.
12. On December 10, 2008, the United States entered
into an agreement with Israel to extend the period that
the 2004 Agreement is in force through December 31,
2009, to allow additional time for the two governments
to conclude an agreement to replace the 2004 Agreement.
13. In Proclamation 8334 of December 31, 2008, the
President determined that it was necessary in order to
maintain the general level of reciprocal and mutually
advantageous concessions with respect to Israel
provided for by the USIFTA to extend such duty-free
treatment through December 31, 2009. In that
proclamation, the President also modified the
Harmonized Tariff Schedule of the United States (HTS)
to provide duty-free access into the United States
through December 31, 2009, for specified quantities of
certain agricultural products of Israel.
14. On December 6, 2009, the United States entered into
a further agreement with Israel to extend the period
that the 2004 Agreement is in force through December
31, 2010, to allow for further negotiations on an
agreement to replace the 2004 Agreement.
15. In Proclamation 8467 of December 23, 2009, I
determined that it was necessary in order to maintain
the general level of reciprocal and mutually
advantageous concessions with respect to Israel
provided for by the USIFTA to extend such duty-free
treatment through December 31, 2010. In that
proclamation, I also modified the HTS to provide duty-
free access into the United States through December 31,
2010, for specified quantities of certain agricultural
products of Israel.
16. On December 12, 2010, the United States entered
into a further agreement with Israel to extend the
period that the 2004 Agreement is in force through
December 31, 2011, to allow for further negotiations on
an agreement to replace the 2004 Agreement.
17. Pursuant to section 4(b) of the USIFTA Act, I have
determined that it is necessary, in order to maintain
the general level of reciprocal and mutually
advantageous concessions with respect to Israel
provided for by the USIFTA, to provide duty-free access
into the United States through the close of December
31, 2011, for specified quantities of certain
agricultural products of Israel.
18. During the Uruguay Round of Multilateral Trade
Negotiations (the ``Uruguay Round''), a group of major
trading countries agreed to reciprocal elimination of
tariffs on certain pharmaceuticals and chemical
intermediates, and that participants in this agreement
would revise periodically the list of products subject
to duty-free treatment. On December 13, 1996, as the
result of negotiations under the auspices of the World
Trade Organization (WTO), the United States and 16
other WTO members agreed to eliminate tariffs on
additional pharmaceuticals and chemical intermediates.
The United States implemented this agreement in
Proclamation 6982 of April 1, 1997. In 1998, the United
States and 21 other WTO members negotiated a second
revision to the list of products subject to duty-free
treatment. The United
[[Page 81079]]
States implemented this revision in Proclamation 7207
of July 1, 1999. In 2006, the United States and 30
other WTO members concluded negotiations, under the
auspices of the WTO, on a further revision to the list
of pharmaceuticals and chemical intermediates subject
to duty-free treatment. The United States implemented
this revision in Proclamation 8095 of December 29,
2006. The United States and 31 other WTO members have
negotiated, under the auspices of the WTO, a fourth
revision to the list of pharmaceuticals and chemical
intermediates subject to duty-free treatment.
19. Section 111(b) of the Uruguay Round Agreements Act
(URAA) (19 U.S.C. 3521(b)) authorizes the President
under specified circumstances to proclaim the
modification of any duty or staged rate reduction of
any duty set forth in Schedule XX-United States of
America, annexed to the Marrakesh Protocol to the GATT
1994 (Schedule XX) for products that were the subject
of reciprocal duty elimination negotiations during the
Uruguay Round, if the United States agrees to such
action in a multilateral negotiation under the auspices
of the WTO.
20. On September 15, 2010, consistent with section 115
of the URAA (19 U.S.C. 3524), the USTR submitted a
report to the Committee on Ways and Means of the House
of Representatives and the Committee on Finance of the
Senate that set forth the proposed further revision to
the list of pharmaceuticals and chemical intermediates
subject to duty-free treatment. The consultation and
layover period specified in section 115 ended on
November 14, 2010.
21. Pursuant to section 111(b) of the URAA, I have
determined that Schedule XX should be modified to
reflect the implementation by the United States of the
multilateral agreement on certain pharmaceuticals and
chemical intermediates negotiated under the auspices of
the WTO. In addition, I have determined that the
pharmaceuticals appendix to the HTS should be modified
to reflect the duty eliminations provided for in that
agreement.
22. Section 604 of the Trade Act of 1974, as amended
(19 U.S.C. 2483), authorizes the President to embody in
the HTS the substance of the relevant provisions of
that Act, and of other Acts affecting import treatment,
and actions thereunder, including the removal,
modification, continuance, or imposition of any rate of
duty or other import restriction.
NOW, THEREFORE, I, BARACK OBAMA, President of the
United States of America, by virtue of the authority
vested in me by the Constitution and the laws of the
United States of America, including but not limited to
section 104 of the AGOA, title V and section 604 of the
1974 Act, section 4 of the USIFTA Act, and section 111
of the URAA do proclaim that:
(1) The designation of the DRC as a beneficiary
sub-Saharan African country for purposes of section
506A of the 1974 Act is terminated, effective on
January 1, 2011.
(2) In order to reflect in the HTS that beginning
on January 1, 2011, the DRC shall no longer be
designated as a beneficiary sub-Saharan African
country, general note 16(a) to the HTS is modified by
deleting ``Democratic Republic of Congo'' from the list
of beneficiary sub-Saharan African countries.
(3) In order to implement U.S. tariff commitments
under the 2004 Agreement through December 31, 2011, the
HTS is modified as provided in the Annex to this
proclamation.
(4)(a) The modifications to the HTS made by the
Annex to this proclamation shall be effective with
respect to goods that are the product of Israel and are
entered, or withdrawn from warehouse for consumption,
on or after January 1, 2011.
(b) The provisions of subchapter VIII of chapter 99 of the HTS, as modified
by the Annex to this proclamation, shall continue in effect through
December 31, 2011.
(5) In order to implement the multilateral
agreement negotiated under the auspices of the WTO to
eliminate tariffs on certain pharmaceutical
[[Page 81080]]
products and chemical intermediates, and to make
technical corrections in the tariff treatment accorded
to such products, the HTS is modified as set forth in
Publication 4208 of the United States International
Trade Commission, entitled ``Modifications to the
Harmonized Tariff Schedule of the United States to
Implement Changes to the Pharmaceutical Appendix''
(Publication 4208), which is incorporated by reference
into this proclamation.
(6) The modifications to the HTS made in
Publication 4208 shall be effective with respect to
articles entered, or withdrawn from warehouse for
consumption, on or after January 1, 2011.
(7) Any provisions of previous proclamations and
Executive Orders that are inconsistent with the actions
taken in this proclamation are superseded to the extent
of such inconsistency.
IN WITNESS WHEREOF, I have hereunto set my hand this
twenty-first day of December, in the year of our Lord
two thousand ten, and of the Independence of the United
States of America the two hundred and thirty-fifth.
(Presidential Sig.)
Billing code 3195-W1-P
[[Page 81081]]
[GRAPHIC] [TIFF OMITTED] TD27DE10.002
[FR Doc. 2010-32610
Filed 12-23-10; 8:45 am]
Billing code 7020-02-C